Large scale genetic screen identifies MAP17 as protein bypassing TNF-induced growth arrest
Authors:
- 1 May 2007
- journal article
- research article
- Published by Wiley in Journal of Cellular Biochemistry
- Vol. 101 (1) , 112-121
Abstract
Although activated macrophages destroy cancer cells more effectively than normal cells, the ability to escape activated macrophages is a characteristic of tumor cells. One of the mechanisms responsible for the specific killing of tumor cells by macrophages is the production of the cytokine tumor necrosis factor (TNF) alpha. Therefore, resistance to TNF may provide such cancer cells a selective advantage against host elimination. With the aim of identifying genes with these properties we undertook a large scale genetic screen to identify genes able to bypass TNF-induced G1 arrest. We identified MAP17, a small 17 kDa nonglycosylated membrane protein that localizes to the plasma membrane and the Golgi apparatus. Ectopic expression of MAP17 in tumor cells prevents TNF-induced G1 arrest by impairing p21waf1 induction. However, expression of MAP17 does not inhibit TNF-induced apoptosis in Me180-sensitive tumor cells. The inhibition of TNF is specific since MAP17 does not alter the response to other cytokines such as IFNgamma. As described in the Xenopus oocyte system, MAP17 increases the uptake of mannose in some cells, but this effect is not responsible for TNF bypass. We have also analyzed the expression of MAP17 mRNA in a panel of cell lines. MAP17 is expressed in 30% of cell lines of different origin. However, MAP17 mRNA expression did not correlate with TNF resistance. Our data indicates that although MAP17 expression might bypass TNF-induced growth arrest, it is not the only determinant of this response.Keywords
This publication has 31 references indexed in Scilit:
- Overexpression of cyclin D1 inhibits TNF‐induced growth arrestJournal of Cellular Biochemistry, 2003
- TNF-R1 Signaling: A Beautiful PathwayScience, 2002
- The Membrane-Associated Protein pKe#192/MAP17 in Human KeratinocytesJournal of Investigative Dermatology, 2000
- Selective Activation of Ha-rasval12Oncogene Increases Susceptibility of NIH/3T3 Cells to TNF-αExperimental Cell Research, 1999
- MaRX: An Approach to Genetics in Mammalian CellsScience, 1999
- Tumour necrosis factor as an anticancer agentEuropean Journal of Cancer and Clinical Oncology, 1990
- Tumor necrosis factorsSeminars in Surgical Oncology, 1989
- Distinct mechanisms of interferon‐gamma and tumor necrosis factor‐alpha action in oncogene‐transformed mouse fibroblastsJournal of Cellular Biochemistry, 1988
- Recombinant Human Tumor Necrosis Factor-α: Effects on Proliferation of Normal and Transformed Cells in VitroScience, 1985
- On the Origin of Cancer CellsScience, 1956